Skip to main content
Premium Trial:

Request an Annual Quote

Power3 Hires Middle East Distributor for Proteomic-Based Breast Cancer Dx

NEW YORK (GenomeWeb News) — Power3 Medical Products said yesterday it has hired Bahrain-based Financial Advisory House to market and distribute a proteomics-based breast cancer test in 12 countries in the Middle East.
 
Under the agreement, FAH’s Medical Equipment Suppliers division will market and distribute Power3’s BC-SeraPro breast cancer diagnostic in Bahrain; Egypt; Iraq; Jordan; Kuwait; Lebanon; Saudi Arabia; Oman; Qatar; Syria; the United Arab Emirates; and Yemen.
 
BC-SeraPro is a proteomics-based blood serum diagnostic used for the early screening and diagnosis of breast cancer. FAH will market and distribute it to clinics and physicians in these countries, while the tests will be analyzed in Power3's Houston-based CLIA lab.
 
Financial terms of the agreement were not released.
 
“We selected the Middle East as our initial market because the healthcare systems in these particular countries are open to providing a test that offers new and innovative technologies for earlier detection of breast cancer,”Power3 CEO Steven Rash said in a statement.
 
The company also is seeking other distributors for the blood serum-based breast cancer test and is involved in discussions with international and domestic partners, it said.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.